Priority Healthcare Added To NASDAQ Biotechnology Index LAKE MARY, Fla., Nov. 14 /PRNewswire-FirstCall/ -- Priority Healthcare Corporation will be added to the NASDAQ Biotechnology Index effective Monday, November 24, 2003. "We are very pleased to join the NASDAQ Biotechnology Index, which is composed of the largest and most actively traded NASDAQ biotechnology and pharmaceutical companies as classified by FTSE. This listing is a testament to Priority's strength and reliability as a market leader in specialty pharmacy and distribution. Since 2000, the NASDAQ Biotechnology Index has outperformed the NASDAQ Composite, the S&P 500, and the Dow Jones Industrial Average," said Steve Cosler, President and Chief Executive Officer. "Priority Healthcare's commitment to serving patients, physicians, payors and pharmaceutical manufacturers continues to be a driving factor in the growth of our company and the solid returns we've earned for our investors." The NASDAQ Biotechnology Index is designed to provide investors with a benchmark of stock performance for biotechnology and pharmaceutical companies as defined by the FTSE(TM) Global Classification System. This includes companies where the majority of revenue is derived from the sale, licensing, and/or distribution of biopharmaceutical and pharmaceutical medications. The NASDAQ Biotechnology Index is calculated under a modified capitalization- weighted methodology. For more information on the NASDAQ Biotechnology Index, please visit http://www.nasdaq.com/. About Priority Healthcare Corporation Priority Healthcare Corporation is a national specialty pharmacy and distributor that provides biopharmaceuticals, complex therapies, and related disease treatment programs and services. Priority Healthcare provides comprehensive programs for patients, payors, physicians, and pharmaceutical manufacturers for a growing number of disease states including cancer, hepatitis C, respiratory and pulmonary conditions, infertility, rheumatoid arthritis, hemophilia, and multiple sclerosis. Additional information regarding Priority Healthcare is available at http://www.priorityhealthcare.com/ Certain statements included in this press release, which are not historical facts, are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our expectations or beliefs and involve certain risks and uncertainties, including those described in our public filings with the United States Securities and Exchange Commission; also including, but not limited to, changes in interest rates, competitive pressures, changes in customer mix, changes in third party reimbursement rates, financial stability of major customers, changes in government regulations or the interpretation of these regulations, changes in supplier relationships, growth opportunities, cost savings, revenue enhancements, synergies and other benefits anticipated from acquisition transactions, difficulties relative to integrating acquired businesses, the accounting and tax treatment of acquisitions, and asserted and unasserted claims, which could cause actual results to differ from those in the forward-looking statements. The forward-looking statements by their nature involve substantial risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date herein. http://www.newscom.com/cgi-bin/prnh/20030417/PHCLOGO http://photoarchive.ap.org/ DATASOURCE: Priority Healthcare Corporation CONTACT: Financial, Stephen Saft, Chief Financial Officer, +1-407-804-6700, or Media, Kirsten Ayars, Public Relations Manager, +1-407-804-6700, both of Priority Healthcare Web site: http://www.priorityhealthcare.com/

Copyright